Informationen:
Fehler:
ID
31081
Beschreibung
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00850577
Link
https://clinicaltrials.gov/show/NCT00850577
Stichworte
Versionen (1)
- 19.07.18 19.07.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
19. Juli 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-small Cell Lung Cancer (NSCLC) NCT00850577
Eligibility Non-small Cell Lung Cancer (NSCLC) NCT00850577
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-small Cell Lung Cancer (NSCLC) NCT00850577
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
ECOG performance status
Item
ecog performance status (ps) <=1
boolean
C1520224 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma TNM clinical staging | Pleural Effusion, Malignant | Non-small cell lung cancer recurrent
Item
histologically or cytologically confirmed, stage iiib (malignant pleural effusion), stage iv or recurrent nsclc
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0080032 (UMLS CUI [2])
C0278517 (UMLS CUI [3])
C3258246 (UMLS CUI [1,2])
C0080032 (UMLS CUI [2])
C0278517 (UMLS CUI [3])
Measurable Disease
Item
measurable disease by recist guidelines
boolean
C1513041 (UMLS CUI [1])
Histology Squamous Cells Predominant
Item
evidence of predominantly squamous-cell histology
boolean
C4048239 (UMLS CUI [1,1])
C0221910 (UMLS CUI [1,2])
C1542147 (UMLS CUI [1,3])
C0221910 (UMLS CUI [1,2])
C1542147 (UMLS CUI [1,3])
CNS metastases
Item
known cns metastases
boolean
C0686377 (UMLS CUI [1])
Cancer treatment Systemic Non-Small Cell Lung Carcinoma
Item
any prior antineoplastic systemic regimens for nsclc
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
C0205373 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
Bleeding risk Excessive | Anticoagulation Therapy | Thrombotic stroke | Embolic stroke
Item
excessive risk of bleeding (including use of therapeutic anticoagulation) and history of thrombotic or embolic cerebrovascular accident
boolean
C3251812 (UMLS CUI [1,1])
C0442802 (UMLS CUI [1,2])
C0003281 (UMLS CUI [2])
C0242129 (UMLS CUI [3])
C0262469 (UMLS CUI [4])
C0442802 (UMLS CUI [1,2])
C0003281 (UMLS CUI [2])
C0242129 (UMLS CUI [3])
C0262469 (UMLS CUI [4])
Hemoptysis Gross
Item
gross hemoptysis (≥1/2 tsp of red blood)
boolean
C0019079 (UMLS CUI [1,1])
C0439806 (UMLS CUI [1,2])
C0439806 (UMLS CUI [1,2])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Cardiovascular Disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Abdominal fistula | Gastrointestinal perforation | Abdominal Abscess
Item
history of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within the past 6 months
boolean
C1879311 (UMLS CUI [1])
C0151664 (UMLS CUI [2])
C0243001 (UMLS CUI [3])
C0151664 (UMLS CUI [2])
C0243001 (UMLS CUI [3])
Non healing wound Serious | Peptic Ulcer | Bone Fracture Non-healed | Secondary malignant neoplasm of skin bleeding
Item
serious non-healing wound, active peptic ulcer, non-healing bone fracture, or bleeding skin metastasis
boolean
C0750433 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0030920 (UMLS CUI [2])
C0016658 (UMLS CUI [3,1])
C0205301 (UMLS CUI [3,2])
C0153687 (UMLS CUI [4,1])
C0019080 (UMLS CUI [4,2])
C0205404 (UMLS CUI [1,2])
C0030920 (UMLS CUI [2])
C0016658 (UMLS CUI [3,1])
C0205301 (UMLS CUI [3,2])
C0153687 (UMLS CUI [4,1])
C0019080 (UMLS CUI [4,2])